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134 enrichment analysis was performed using the Overrepresentation Analysis (ORA) 135 against a knowledge database, the Pathway-associated metabolite sets library, which 136 contains 99 metabolite sets based on normal metabolic pathways, in the Small 137 Molecular Pathway Database (SMPDB) [39] .
139 2. Results

140
Our previous study reported that levels of 149 and 181 metabolites in the muscle 141 at 24 and 48 hpi (hour post injection), respectively, and those of 24 and 12 metabolites 142 in the hepatopancreas at 24 and 48 hpi, respectively, were found significantly 143 different [34] , between the saline-injected (SAI) and CHH double-stranded 144 RNA-injected (CHH DSI) animals (Procambarus clarkii). Among those 145 significantly changed metabolites, those that are directly related to carbohydrate and 146 energy metabolism have been analyzed [34] . In this further study, to give a more 147 comprehensive survey of the effects of silencing CHH gene expression on tissue 148 metabolism, all significantly changed metabolites were analyzed using MetPA 
171
In the hepatopancreas, MSEA analysis showed that Fatty acid biosynthesis was 172 significantly impacted at 24 hpi ( 180 and nucleotide metabolism will be described in details.
181
In the muscle at 24 hpi, levels of several amino acids, including alanine, arginine, 182 aspartate, glutamate, glutamine, proline and serine decreased significantly, while 183 those of 5 amino acids or related compounds, asparagine, anserine, histidine, 184 histamine, and -alanine, significantly increased (Fig 1) . At 48hpi, the changes were 185 similar to those at 24 hpi, with aspartate no longer significantly decreased and 186 anserine no longer significantly increased (Fig 1) .
187
In response to silencing of CHH gene expression in the muscle at 24 hpi, 
193
In the hepatopancreas, with regard to nucleotide metabolism only levels of 194 thymine and urea were significantly decreased at 24 hpi and no significant change 195 was found at 48 hpi. 
206
In this study, comprehensive analysis of the metabolite whose levels were 207 significantly changed by silencing CHH gene expression revealed that the effects 208 were not limited to carbohydrate and energy metabolism as previous studies had 209 indicated [22, 33, 34] . Analysis of the metabolite whose levels were significantly 210 changed by silencing CHH gene expression revealed that the effects were not limited 211 to carbohydrate and energy metabolism as previous studies had indicated. Thus, 212 combined data derived from MetPA and MSEA revealed additionally that, in the 213 muscle nucleotide metabolism was severely reduced, likely due to a negatively 214 impacted pentose phosphate pathway (PPP), and amino acid metabolism significantly 215 affected that would likely result in slowing down protein synthesis, while in the 216 hepatopancreas fatty acid biosynthesis was significantly affected.
217
Specifically, in the muscle, one of the pathways significantly negatively affected 218 at both 24 hpi and 48 hpi is Nicotinate and nicotinamide metabolism, which concerns 219 the metabolism of two nicotinamide coenzymes (NAD + and NADP + ) and has 220 metabolically diverse ramification, with levels of both coenzymes being significantly 221 reduced ( 229 via PRPP (5-phosphoribosyl 1-pyrophosphate), is a precursor to nucleotide 230 biosynthesis [43] (see Fig. 3 ). Thus, a negatively impacted PPP would, as a result of 231 low NADP + levels, decrease nucleotide biosynthesis, which was clearly demonstrated 232 by significantly lower levels of nucleotides across the board (Fig. 2, 3) .
233
Another pathway that was significantly affected in the muscle by CHH gene 234 silencing at 24 hpi is Pyruvate metabolism ( . Thus, an increase in 255 asparagine levels was likely a spillover from a TCA cycle thus inhibited (Fig. 3) . In 256 addition, increases in -alanine, histidine, and anserine levels ( Fig. 1 ) are worth 257 mentioning. Carnosine (not detected) is a dipeptide, highly concentrated in the 258 muscle and brain, consists of -alanine and histidine, and could be converted to 259 anserine via methylation of the histidine residue ( Fig. 3) 324 previous ones [22, 28, 29, 31, 33, 34, 49, 50] , a comprehensive scheme of CHH roles 325 in the 2 target tissues is proposed (Fig. 4) . 517 Figure 4 Proposed metabolic roles of CHH in the muscle and hepatopancreas. Under 518 conditions when its release from the eyestalk ganglia into the hemolymph is 519 stimulated (Webster, 1996; Chang et al., 1998; Chang et al., 1999; Zou et al., 520 2003; Lorenzon et al., 2004; Lin et al., 2013) , CHH acts on and differentially 521 regulates its target tissues. Hence, while CHH stimulates glycogenolysis in both 522 target tissues, resulting in higher levels of glucose (Parvathy, 1972; Keller and 523 Andrew, 1973; Sedlmeier, 1981 Sedlmeier, , 1987 Sedlmeier and Keller, 1983 ) that drives 524 glycolytic flux (Santos and Keller, 1993a,b) , in the hepatopancreas, CHH 525 additionally enhances lipolysis (Santos et al., 1997 ; the present study). Glucose 526
and free fatty acids are released into the hemolymph and taken up by the muscle 527
where they are further metabolized via glycolysis and TCA cycle, respectively, for 528 ATP production. In the muscle, central to the effects of CHH is a stimulated 529
Nicotinate and nicotinamide metabolism, which provides two nicotinamide 530 coenzymes (NAD + and NADP + ) that drive glycolysis and TCA cycle, and the 531 pentose phosphate pathway, respectively (Li et al., 2017 ; the present study), 532
resulting in more ATP supply and higher protein and nucleic acid turnover. 533
Additionally, CHH may provide protective effects to the muscle by increasing 534 carnosine levels.
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